Zu "51037-30-0" wurden 2 Artikel gefunden!

Für die Filterung wurden keine Ergebnisse gefunden!
Acipimox
Acipimox

Artikelnummer: LKT-A0833.1

Yellowish white crystalline powder. Acipimox inhibits lipolysis in peripheral tissues and induces large reduction in circulatingserum-free fatty acids. The mechanism of triglyceride lowering appears to be an increase of VLDL-Tg clearance.
Anwendung: Metabolic studies
CAS 51037-30-0
MW: 154,12 D
ab 128,00 €
Bewerten
Acipimox
Acipimox

Artikelnummer: Cay26090-500

Acipimox is an antilipolytic agent. It inhibits lipolysis induced by noradrenaline and theophylline in rat epididymal adipocytes when used at a concentration of 1 µM. Acipimox (3 and 12 mg/kg, p.o.) decreases plasma free fatty acid levels in rats. It reduces plasma fatty acid concentration, the number of...
Schlagworte: 5-methyl-2-pyrazinecarboxylic acid, 4-oxide
Anwendung: Hypolipidemic agent, lipolysis inhibitor
CAS 51037-30-0
MW: 154.1 D
ab 67,00 €
Bewerten